HNRNPCP1

Across TCGA pan-cancer cohorts, HNRNPCP1 RNA is linked to patient survival in 26 of 34 cancer types, making it the most broadly survival-associated HNRNPCP1 data layer.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher HNRNPCP1 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated HNRNPCP1 expression acts as an unfavorable survival marker, although some lineages such as THYM and ESCA show a favorable association.

ACC, MESO, and LIHC are the cancer types where HNRNPCP1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ACC	OS	Median	All	0.343	0.849	<.001	127	view →
MESO	DFS	Median	All	0.209	0.634	.001	78	view →
LIHC	OS	Quartile	II,III,IV	0.488	0.763	.001	67	view →
KIRC	DFS	Tertile	II,III,IV	0.361	0.672	.001	61	view →
LGG	DFS	Median	All	0.634	0.836	<.001	50	view →
READ	OS	Median	III,IV	0.791	0.981	<.001	48	view →
THYM	OS	Tertile	All	1.000	0.696	.003	30	view →
ESCA	OS	Median	II,III,IV	0.797	0.603	.008	28	view →
THCA	DFS	Quartile	III,IV	0.962	0.827	.010	27	view →
HNSC	OS	Median	All	0.617	0.792	.001	20	view →
CHOL	DFS	Median	All	0.123	0.759	.004	18	view →
SKCM	DFS	Median	II,III,IV	0.168	0.468	.003	15	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 26 lineages.

HNRNPCP1–ACC (OS)

Open the ACC breakdown →